Literature DB >> 8425936

Factor structure and scoring of the SKT test battery.

Y S Kim1, D W Nibbelink, J E Overall.   

Abstract

The SKT (Syndrom Kurztest) has been used in the assessment of treatment responses in numerous clinical trials for treatment of dementia in German-speaking Europe. Data from 265 patients with mild to moderate Alzheimer's disease in a study conducted in the U.S. were analyzed to evaluate factor structure, common and specific subtest content, reliability, and concurrent validity. Results confirm the presence of two primary factors of memory and attention. Test-retest reliability of the factor scores was estimated to be .75 and .93. Test-retest reliability of the composite SKT total score was .90. The correlations between the SKT memory and attention factor scores and the MMSE and ADAS measurements of dementia also support validity with regard to the broader construct of cognitive dysfunction.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8425936     DOI： 10.1002/1097-4679(199301)49:1<61::aid-jclp2270490109>3.0.co;2-b

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN： 0021-9762


  15 in total

1.  Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials.

Authors:  Siegfried Kasper
Journal:  Wien Med Wochenschr       Date:  2015-06-20

Review 2.  [Hippocampal stroke].

Authors:  J D Rollnik; B Traitel; B Dietrich; O Lenz
Journal:  Nervenarzt       Date:  2015-02       Impact factor: 1.214

Review 3.  Effects of Ginkgo biloba in dementia: systematic review and meta-analysis.

Authors:  Stefan Weinmann; Stephanie Roll; Christoph Schwarzbach; Christoph Vauth; Stefan N Willich
Journal:  BMC Geriatr       Date:  2010-03-17       Impact factor: 3.921

4.  Validation of Chinese Version of SKT (Syndrom Kurztest): A Short Cognitive Performance Test for the Assessment of Memory and Attention.

Authors:  Yao Lu; Jingchao Hu; Mark Stemmler; Qihao Guo
Journal:  Diagnostics (Basel)       Date:  2021-12-01

5.  Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.

Authors:  Natalia Bachinskaya; Robert Hoerr; Ralf Ihl
Journal:  Neuropsychiatr Dis Treat       Date:  2011-04-20       Impact factor: 2.570

6.  Memantine for dementia.

Authors:  Rupert McShane; Maggie J Westby; Emmert Roberts; Neda Minakaran; Lon Schneider; Lucy E Farrimond; Nicola Maayan; Jennifer Ware; Jean Debarros
Journal:  Cochrane Database Syst Rev       Date:  2019-03-20

7.  Evidence-Based Research in Complementary and Alternative Medicine III: Treatment of Patients with Alzheimer's Disease.

Authors:  Francesco Chiappelli; Audrey M Navarro; David R Moradi; Ercolano Manfrini; Paolo Prolo
Journal:  Evid Based Complement Alternat Med       Date:  2006-11-10       Impact factor: 2.629

8.  Effect of piracetam on the cognitive performance of patients undergoing coronary bypass surgery: A meta-analysis.

Authors:  Yu Fang; Zhandong Qiu; Wentao Hu; Jia Yang; Xiyan Yi; Liangjiang Huang; Suming Zhang
Journal:  Exp Ther Med       Date:  2013-11-26       Impact factor: 2.447

9.  A Systematic Review and Meta-Analysis of Ginkgo biloba in Neuropsychiatric Disorders: From Ancient Tradition to Modern-Day Medicine.

Authors:  Natascia Brondino; Annalisa De Silvestri; Simona Re; Niccolò Lanati; Pia Thiemann; Anna Verna; Enzo Emanuele; Pierluigi Politi
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-28       Impact factor: 2.629

10.  Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial.

Authors:  Andrey Scripnikov; Alexander Khomenko; Oleksandr Napryeyenko
Journal:  Wien Med Wochenschr       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.